Table 3.

Saturation effect analysis of AIP on uric acid levels and the prevalence of hyperuricemia.

	Model 1		Model 2		Model 3
	β(95%CI)	P	β(95%CI)	P	β(95%CI)	P
Uric acid
Inflection point(K)	0.578		0.571		0.588
<K effect size OR(95%CI)	1.438 (1.345,1.531)	<0.001	1.197(1.108,1.285)	<0.001	0.854(0.762,0.946)	<0.001
>K effect size OR(95%CI)	-1.088 (-2.24,0.065)	0.064	-0.849(-1.959,0.26)		-0.893(-0.2101,0.316)	0.147
P for log likelihood ratio test	<0.001		<0.001		<0.001
Hyperuricemia
Inflection point(K)	0.524		0.547		0.573
<K effect size OR(95%CI)	5.587 (4.652,6.712)	<0.001	7.496 (6.176,9.099)	<0.001	4.4 (3.528,5.488)	<0.001
>K effect size OR(95%CI)	0.311 (0.082,1.182)	0.086	0.489 (0.109,2.191)	0.349	0.313 (0.044,2.242)	0.247
P for log likelihood ratio test	<0.001		<0.001		<0.001

AIP, atherogenic index of plasma; BMI, body mass index; HTN, hypertension; LDL-C, low-density lipoprotein-cholesterol; TC, total cholesterol; OR, odds ratio. Model 1: univariable;Model 2: age,sex, race; Model 3: age, sex, race, family poverty income ratio, BMI, waist circumference, education level, alcohol consumption status, smoking status, marital status, diabetes, HTN, serum creatinine, coronary heart disease, heart failure, stroke, sedentary time, LDL-C, TC, glycohemoglobin, urine albumin/urine creatinine, urinary creatinine, urinary albumin.